TC Biopharm (Holdings) Plc (TCBP)
NASDAQ: TCBP · IEX Real-Time Price · USD
0.891
+0.056 (6.74%)
At close: Jul 2, 2024, 3:58 PM
0.913
+0.022 (2.43%)
After-hours: Jul 2, 2024, 7:54 PM EDT

TC Biopharm (Holdings) Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019
Market Capitalization
313---
Market Cap Growth
-85.82%-65.69%----
Enterprise Value
4012033
PE Ratio
--0.14-1.92---
PS Ratio
--0.66---
PB Ratio
2.080.317.63---
P/FCF Ratio
--0.08-0.16---
P/OCF Ratio
--0.08-0.17---
EV/Sales Ratio
--0.137.621.150.72
EV/EBITDA Ratio
--0.030.11-1.43-0.43-0.43
EV/EBIT Ratio
--0.020.13-1.31-0.36-0.38
EV/FCF Ratio
--0.02-0.03-2.31-0.52-0.29
Debt / Equity Ratio
1.600.678.39-1.00-0.90-1.35
Debt / EBITDA Ratio
--0.290.62-1.58-0.57-0.60
Debt / FCF Ratio
--0.17-0.18-2.55-0.69-0.40
Quick Ratio
0.210.520.520.120.250.58
Current Ratio
0.881.200.810.190.531.09
Asset Turnover
-00.400.260.23-
Interest Coverage
--83.260.55-3.36-21.70-24.03
Return on Equity (ROE)
--391.60%16.20%136.40%185.40%-
Return on Assets (ROA)
--58.40%-13.60%-177.60%-62.70%-
Return on Capital (ROIC)
--317.39%-388.60%-9649.88%1968.76%-738.57%
Earnings Yield
-715.39%-51.95%---
FCF Yield
-1290.45%-612.14%---
Buyback Yield / Dilution
-4285.72%-799.07%-24.02%---
Total Shareholder Return
-4285.72%-799.07%-24.02%---
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).